Recent case study highlights the importance of applying statistical rigor throughout the development and validation processes of biomarkers.
Elisabeth Coart, PhD
Advertisement
Articles by Elisabeth Coart, PhD
The development and qualification of biomarkers are keys to the future of drug development and precision medicine, particularly in oncology.
Advertisement
Latest Updated Articles
- Integration of Biomarker Validation in Oncology Trials
Published: August 13th 2020 | Updated:
Integration of Biomarker Validation in Clinical Development in OncologyPublished: May 28th 2020 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NIH Implements Contingency Plan as Government Shutdown Impacts Research Funding
2
AI in Action: Breaking Down Clinical Trial Bottlenecks
3
Focusing on Site Needs and Challenges: Quick Tips for Sponsors/CROs
4
2025 SCRS Global Site Solutions Summit: How Technology Vendors Can Reduce Site Burden and Improve Trial Execution
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
